Scientists discover off-switch for 'molecular machine' active in many diseases

February 6, 2018, University of Queensland
Researchers have discovered how a molecular 'machine' -- that drives inflammation in a range of diseases -- turns off in healthy cells. Credit: Kate Schroder, The University of Queensland

A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer's and gout.

University of Queensland researchers have uncovered how an process automatically switches off in healthy cells, and are now investigating ways to stop it manually when it goes awry.

UQ's Institute for Molecular Bioscience (IMB) researcher Associate Professor Kate Schroder said this inflammation pathway drove many different diseases.

"Now that we understand how this pathway naturally turns off in health, we can investigate why it doesn't turn off in disease—so it's very exciting," Dr Schroder said.

Her work at IMB's Centre for Inflammation and Disease Research focuses on inflammasomes, which are machine-like protein complexes at the heart of inflammation and disease.

"These complexes form when an infection, injury or other disturbance is detected by the immune system, and they send messages to immune cells to tell them to respond," Dr Schroder said.

"If the disturbance can't be cleared, such as in the case of amyloid plaques in Alzheimer's, these molecular machines continue to fire, resulting in neurodegenerative damage from the sustained inflammation."

Kate Schroder is Deputy Director, IMB Centre for Inflammation and Disease Research at the University of Queensland. Credit: The University of Queensland

Dr Schroder's team, led by Dr Dave Boucher, discovered that inflammasomes normally work with an in-built timer switch, to ensure they only fire for a specific length of time once triggered.

"The inflammasome initiates the by activating a protein that functions like a pair of scissors, and cuts itself and other proteins," Dr Schroder said.

"What we've found is that after a period of time this protein cuts itself a second time to turn off the pathway, so if we can tweak this system we may be able to turn it off manually in ."

Dr Schroder's laboratory has begun studying the inflammasome in fatty , a rapidly growing health issue due to the increasing global incidence of obesity and diabetes.

"In some patients with this condition the liver becomes increasingly fatty and inflamed, and this can lead to cirrhosis - which can require - or even liver cancer."

Compounds to block have been developed by IMB researchers including Dr Schroder, and are being commercialised by start-up drug development company Inflazome Ltd.

Explore further: The role of monosodium urate crystals in gout

Related Stories

The role of monosodium urate crystals in gout

September 20, 2017
An attack of gout is said to be like your joint catching fire, and someone slamming it with a hammer to put out the flames. Now A*STAR researchers have identified how the build-up of monosodium urate (MSU) crystals in the ...

Of mice and cheeseburgers: Experimental drug reverses obesity-related liver disease

August 3, 2017
A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet—non-alcoholic fatty liver disease.

Effect of gut bacteria on specific immune cells underlies persistent liver inflammation

January 16, 2018
Persistent liver inflammation in sufferers of chronic viral hepatitis is likely caused by interactions between pro-inflammatory immune cells in the liver and products from gut bacteria, according to new work involving A*STAR ...

Scientists make surprising finding in stroke research

March 16, 2015
Scientists at The University of Manchester have made an important new discovery about the brain's immune system that could lead to potential new treatments for stroke and other related conditions.

Unveiling the biology behind nonalcoholic fatty liver disease

January 17, 2017
EPFL scientists have discovered a new biological mechanism behind nonalcoholic fatty liver disease.

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

Recommended for you

Researchers identify source of molecule linked to nasal polyps, asthma attacks

May 23, 2018
A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies. Researchers ...

Study demonstrates new treatment for severe asthma

May 22, 2018
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat ...

Eczema drug effective against severe asthma

May 21, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable ...

Neuron guidance factor found to play a key role in immune cell function

May 21, 2018
Macrophages are white blood cells involved in a variety of biological functions, from destroying infectious pathogens to repairing damaged tissue. To carry out their different roles, macrophages must first be activated and ...

Immune cells hold promise in slowing down ALS

May 21, 2018
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive ...

First clues to the causes of multiple sclerosis

May 16, 2018
Multiple sclerosis, which affects one in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.